Page last updated: 2024-08-23

atracurium and Muscular Atrophy

atracurium has been researched along with Muscular Atrophy in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blobner, M; Fink, H; Frick, CG; Helming, M; Martyn, JA	1
Blobner, M; Fink, H; Frick, CG; Martyn, J	1
Amygdalou, A; Behrakis, PK; Mandragos, C; Moukas, M; Takis, F; Vassiliou, MP	1

Trials

1 trial(s) available for atracurium and Muscular Atrophy

Article	Year
Muscular mass assessed by ultrasonography after administration of low-dose corticosteroids and muscle relaxants in critically ill hemiplegic patients. Clinical nutrition (Edinburgh, Scotland), 2002, Volume: 21, Issue:4 Topics: Age Factors; APACHE; Atracurium; Critical Illness; Dexamethasone; Dose-Response Relationship, Drug; Female; Glucocorticoids; Hemiplegia; Humans; Intensive Care Units; Male; Middle Aged; Muscle, Skeletal; Muscular Atrophy; Neuromuscular Nondepolarizing Agents; Serum Albumin; Time Factors; Treatment Outcome; Ultrasonography	2002

Article

Year

Muscular mass assessed by ultrasonography after administration of low-dose corticosteroids and muscle relaxants in critically ill hemiplegic patients.

Clinical nutrition (Edinburgh, Scotland), 2002, Volume: 21, Issue:4

Topics: Age Factors; APACHE; Atracurium; Critical Illness; Dexamethasone; Dose-Response Relationship, Drug; Female; Glucocorticoids; Hemiplegia; Humans; Intensive Care Units; Male; Middle Aged; Muscle, Skeletal; Muscular Atrophy; Neuromuscular Nondepolarizing Agents; Serum Albumin; Time Factors; Treatment Outcome; Ultrasonography

2002

Other Studies

2 other study(ies) available for atracurium and Muscular Atrophy

Article	Year
Continuous administration of pyridostigmine improves immobilization-induced neuromuscular weakness. Critical care medicine, 2010, Volume: 38, Issue:3 Topics: Animals; Atracurium; Cholinesterase Inhibitors; Disease Models, Animal; Hindlimb; Immobilization; Infusion Pumps; Infusions, Subcutaneous; Male; Muscle Contraction; Muscle Strength; Muscle Weakness; Muscular Atrophy; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Pyridostigmine Bromide; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic	2010
A single injection of botulinum toxin decreases the margin of safety of neurotransmission at local and distant sites. Anesthesia and analgesia, 2012, Volume: 114, Issue:1 Topics: Animals; Atracurium; Botulinum Toxins; Dose-Response Relationship, Drug; Injections, Intramuscular; Male; Muscle Contraction; Muscle Fatigue; Muscle, Skeletal; Muscular Atrophy; Neuromuscular Blocking Agents; Neuromuscular Nondepolarizing Agents; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Synaptic Transmission; Time Factors; Up-Regulation	2012

Article

Year

Continuous administration of pyridostigmine improves immobilization-induced neuromuscular weakness.

Critical care medicine, 2010, Volume: 38, Issue:3

Topics: Animals; Atracurium; Cholinesterase Inhibitors; Disease Models, Animal; Hindlimb; Immobilization; Infusion Pumps; Infusions, Subcutaneous; Male; Muscle Contraction; Muscle Strength; Muscle Weakness; Muscular Atrophy; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Pyridostigmine Bromide; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic

2010

A single injection of botulinum toxin decreases the margin of safety of neurotransmission at local and distant sites.

Anesthesia and analgesia, 2012, Volume: 114, Issue:1

Topics: Animals; Atracurium; Botulinum Toxins; Dose-Response Relationship, Drug; Injections, Intramuscular; Male; Muscle Contraction; Muscle Fatigue; Muscle, Skeletal; Muscular Atrophy; Neuromuscular Blocking Agents; Neuromuscular Nondepolarizing Agents; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Synaptic Transmission; Time Factors; Up-Regulation

2012